No association between variant DNA repair genes and prostate cancer risk among men of African descent

Prostate

Volumn 70, Issue 2, 2010, Pages 113-119

  Lavender, Nicole A ^a,b   Komolafe, Oyeyemi O ^b   Benford, Marnita ^a,b   Brock, Guy ^b   Moore, Jason H ^c   VanCleave, Tiva T ^a,b   States, J Christopher ^a,b   Kittles, Rick A ^d   Kidd, La Creis R ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Base excision repair; Gene gene interactions; Logistic regression analysis; Multifactor dimensionality reduction; Nucleotide excision repair; Prostate cancer

Indexed keywords

DNA; NUCLEOTIDE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AFRICA; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA REPAIR; EXCISION REPAIR; GENE INTERACTION; GENE LOCUS; GENOTYPE; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA REPAIR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 73449099976     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21048     Document Type: Article

References (43)

1. Poirier MC, Weston A. DNA damage, DNA repair, and muta-genesis. In: Bertino JR, editor. Encyclopedia of Cancer. Boston, MA: Academic Press; 2002. pp. 79-82.
2. Martin FL, Cole KJ, Muir GH, Kooiman GG, Williams JA, Sherwood RA, Grover PL, Phillips DH. Primary cultures of prostate cells and their ability to activate carcinogens. Prostate Cancer Prostatic Dis 2002;5:96-104.
3. Friedberg EC, Walker GC, Siede W. DNA repair and muta-genesis, 2nd edition. Washington: American Society of Microbiology; 2006.
4. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNArepair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-1530.
5. Hu JJ, Hall MC, Grossman L, Hedayati M, McCullough DL, Lohman K, Case LD. Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res 2004;64:1197-1201.
6. Lehmann AR. Nucleotide excision repair and the link with transcription. Trends Biochem Sci 1995;20:402-405.
7. Sancar A, Tang MS. Nucleotide excision repair. Photochem Photobiol 1993;57:905-921.
8. Thompson LH, West MG. XRCC1 keeps DNA from getting stranded. Mutat Res 2000;459:1-18.
9. Wallace SS. AP endonucleases and DNA glycosylases that recognize oxidative DNA damage. Environ Mol Mutagen 1988; 12:431-477.
10. Wu X, Zhao H, Wei Q, Amos CI, Zhang K, Guo Z, Qiao Y, Hong WK, Spitz MR. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 2003;24: 505-509.
11. Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles RA. NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. Prostate Cancer Prostatic Dis 2008;11:349-356.
12. Mechanic LE, Bowman ED, Welsh JA, Khan MA, Hagiwara N, Enewold L, Shields PG, Burdette L, Chanock S, Harris CC. Commongenetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors. Cancer Epidemiol Biomarkers Prev 2007;16:214-222.
13. Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J Urol 2006;175:108-112.
14. American Cancer Society. Cancer facts & figures 2009. Atlanta: American Cancer Society; 2009.
15. Xu Z, Hua LX, Qian LX, Yang J, Wang XR, Zhang W, Wu HF. Relationship between XRCC1 polymorphisms and susceptibility to prostate cancer in men from Han, Southern China. Asian J Androl 2007;9:331-338.
16. Hirata H, Hinoda Y, Tanaka Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, Majid S, Vejdani K, Dahiya R. Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer 2007;43:231-237.
17. van Gils CH, Bostick RM, Stern MC, Taylor JA. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: An example of polymorphisms in the XRCC1 gene. Cancer Epidemiol Biomarkers Prev 2002;11:1279-1284.
18. Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A meta-analysis 1. Int J Med Sci 2007;4:59-71.
19. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006;27:560-567.
20. Vogel U, Overvad K, Wallin H, Tjonneland A, Nexo BA, Raaschou-Nielsen O. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer. Cancer Lett 2005;222:67-74.
21. Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004;25:2433-2441.
22. Park JY, Park SH, Choi JE, Lee SY, Jeon HS, Cha SI, Kim CH, Park JH, Kam S, Park RW, Kim IS, Jung TH. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002;11:993-997.
23. Ritchey JD, Huang WY, Chokkalingam AP, Gao YT, Deng J, Levine P, Stanczyk FZ, Hsing AW. Genetic variants of DNA repair genes and prostate cancer: A population-based study. Cancer Epidemiol Biomarkers Prev 2005;14:1703-1709.
24. Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2004;13: 23-29.
25. Bau DT, Wu HC, Chiu CF, Lin CC, Hsu CM, Wang CL, Wang RF, Tsai FJ. Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Anticancer Res 2007;27:2893-2896.
26. Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, Tosteson TD, Schned AR, Karagas MR. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking, and bladder cancer susceptibility. Carcinogenesis 2006;27:1030-1037.
27. Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, Heard K, Heard K, Tse CK, Keku T. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites:Apopulation- based case-control study. Carcinogenesis 2006;27:1377-1385.
28. Stern MC, Johnson LR, Bell DA, Taylor JA. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1004-1011.
29. Giri VN, Egleston B, Ruth K, Uzzo RG, Chen DY, Buyyounouski M, Raysor S, Hooker S, Torres JB, Ramike T, Mastalski K, Kim TY, Kittles R. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Cancer Prev Res (Phila, PA) 2009;2:244-250.
30. Tian C, Hinds DA, Shigeta R, Kittles R, Ballinger DG, Seldin MF. A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet 2006;79:640-649.
31. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003;19:376-382.
32. Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003;24:150-157.
33. Hahn LW, Moore JH. Ideal discrimination of discrete clinical endpoints using multilocus genotypes. In Silico Biol 2004;4:183-194.
34. Moore JH. Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn 2004;4:795-803.
35. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69:138-147.
36. National Center for Biotechnology Information (NCBI) website, http.www.ncbi.nih.gov.
37. SNP500Cancer database, http://snp500cancer.nci.nih.gov/.
38. Nam RK, Zhang WW, Jewett MA, Trachtenberg J, Klotz LH, Emami M, Sugar L, Sweet J, Toi A, Narod SA. The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Clin Cancer Res 2005;11:8391-8397.
39. Xu J, Zheng SL, Turner A, Isaacs SD, Wiley KE, Hawkins GA, Chang BL, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB. Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res 2002;62:2253-2257.
40. Chen L, Elahi A, Pow-Sang J, Lazarus P, Park J. Association between polymorphism of humanoxoguanine glycosylase 1 and risk of prostate cancer. J Urol 2003;170:2471-2474.
41. Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini S, Sacerdote C, Moore JH, Kelsey KT, Demidenko E, Vineis P, Matullo G. DNA repair polymorphisms modify bladder cancer risk: A multi-factor analytic strategy. Hum Hered 2008;65:105-118.
42. Shriver MD, Kittles RA. Genetic ancestry and the search for personalized genetic histories. Nat Rev Genet 2004;5:611-618.
43. Kittles RA, Chen W, Panguluri RK, Ahaghotu C, Jackson A, Adebamowo CA, Griffin R, Williams T, Ukoli F, Adams-Campbell L, Kwagyan J, Isaacs W, Freeman V, Dunston GM. CYP3A4-V and prostate cancer in African Americans: Causal or confounding association because of population stratification? Hum Genet 2002;110:553-560.